ⓘ Thrombopoietin receptor

                                     

ⓘ Thrombopoietin receptor

The thrombopoietin receptor also known as the myeloproliferative leukemia protein or CD110 is a protein that in humans is encoded by the MPL oncogene.

                                     
  • Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin Romiplastin
  • Thrombopoietin THPO also known as megakaryocyte growth and development factor MGDF is a protein that in humans is encoded by the THPO gene. Thrombopoietin
  • molecule agonist of the c - mpl TpoR receptor which is the physiological target of the hormone thrombopoietin Eltrombopag was discovered as a result
  • Romiplostim rINN, USAN is a fusion protein analog of thrombopoietin a hormone that regulates platelet production. The drug was developed by Amgen and
  • IL - 6 receptor IL - 11 receptor IL - 12 receptor IL - 27 receptor Leukemia inhibitory factor receptor Oncostatin M receptor Type I cytokine receptors include
  • Cytokine receptors are receptors that bind to cytokines. In recent years, the cytokine receptors have come to demand the attention of more investigators
  • interleukin - 31 receptor IL - 31R is a receptor bound and activated by interleukin - 31 IL - 31 It is a heterodimer consisting of IL - 31 receptor A IL31RA
  • receptors are similar to type I cytokine receptors except they do not possess the signature sequence WSXWS that is characteristic of type I receptors
  • a thrombopoietin receptor agonist. Osphena, an estrogen receptor agonist, marketing rights sold to Duchesnay in 2017. Symproic, a μ - opioid receptor antagonist